Open Accessibility Menu

Monthly investment news and growth insights — straight to your inbox. Sign up to our newsletter.

BGF
Accessibility Accessibility
Search
Menu
Close
LinkedIn LinkedIn Youtube YouTube
Looking for funding?
Search
Close
  • St Pierre Groupe
  • Succession planning
  • Case study
  • International expansion
  • Female founders

Intrapharm

  •  South East  •  Growth

Intrapharm is a rapidly expanding speciality pharmaceutical company, with a primary focus on prescription-based and certain over the counter products.

Company
information

Total BGF investment

£2m

Investment date

Aug 2014 - Nov 2015

Head office

Maidenhead

Chair

Shafiq Choudhary

BGF invested in Intrapharm in August 2014 and supported the company’s acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax.

Following a period of sustained growth, with revenues increasing from £4m to £12m during BGF’s investment, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH in November 2015 with all shareholders realising a strong return.